The effectiveness of selfBACK decision support system for neck and low back pain is currently evaluated in a randomized controlled trial (RCT) using pain-related disability as primary outcome. The RCT is targeting patients with neck and/or low back pain admitted for treatment at an outpatient hospital clinic. A process evaluation is carried out as an integrated part of the trial to document the implementation and map the patients experiences with selfBACK as well as the clinicians’ views of the selfBACK intervention. A total of 294 patients have been included in the trial. The results are expected to be published during spring 2022.
Addressing target audiences and expressing needs
- Collaboration
- Venture Capital
- Other type of Investment
We have a prototype of the selfBACK decision support system and we are looking for collaborations to bring the technology into the market and to do further research.
- Research and Technology Organisations
- Academia/ Universities
- Private Investors
R&D, Technology and Innovation aspects
- Current state: prototype evaluated in two randomized clinical trials.
- Next steps: collaboration on further developments of the technology (academia) and exploitation of the current results (industry)
Currently under development
Yes, given access to the technology and trial protocols
To be determined.
- Global
